Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 338

The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.

Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets

Open access
Lv, Wenshan, Booz, George W., Wang, Yangang, Fan, Fan, Roman, Richard J.·2018·European Journal of Pharmacology

Abstract

ABSTRACT Chronic kidney disease (CKD) is a major public health issue. At the histological level, renal fibrosis is the final common pathway of progressive kidney disease irrespective of the initial injury. Considerable evidence now indicates that renal inflammation plays a central role in the initiation and progression of CKD. Some of the inflammatory signaling molecules involved in CKD include: monocyte chemoattractant protein‐1 (MCP‐1), bradykinin B1 receptor (B1R), nuclear factor &kgr;B (NF‐&kgr;B), tumor necrosis factor‐&agr; (TNF&agr;), transforming growth factor &bgr; (TGF‐&bgr;), and platelet‐derived growth factor (PDGF). Multiple antifibrotic factors, such as interleukin‐10 (IL‐10), interferon‐&ggr; (IFN‐&ggr;), bone morphogenetic protein‐7 (BMP‐7), hepatocyte growth factor (HGF) are also downregulated in CKD. Therefore, restoration of the proper balance between pro‐ and antifibrotic signaling pathways could serve as a guiding principle for the design of new antifibrotic strategies that simultaneously target many pathways. The purpose of this review is to summarize the existing body of knowledge regarding activation of cytokine pathways and infiltration of inflammatory cells as a starting point for developing novel antifibrotic therapies to prevent progression of CKD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejphar.2017.12.016

Cites

150 of 150 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 150 references

Cited by

See all 338

Metadata

Authors
Lv, W., Booz, G. W., Wang, Y., Fan, F., & Roman, R. J.
Venue
European Journal of Pharmacology
Publisher
Elsevier BV
Published
2018-02
Volume
820
Pages
65-76
ISSN
0014-2999 (ISSN-L)
OpenAlex
W2772570025
Cited by
338
References
150
FWCI
14.45
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets. https://app.cochat.ai/papers/10.1016/j.ejphar.2017.12.016
The paper
Lv, W., Booz, G. W., Wang, Y., Fan, F., & Roman, R. J. (2018). Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2017.12.016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.